title: Reactive arthritis: clinical aspects and medical management.
abstract: Reactive arthritis (ReA) is an inflammatory arthritis that arises after certain gastrointestinal or genitourinary infections, representing a classic interplay between host and environment. It belongs to the group of arthritidies known as the spondyloarthropathies. The classic syndrome is a triad of symptoms, including the urethra, conjunctiva, and synovium; however, the majority of patients do not present with this triad. Diagnostic criteria for ReA exist, but data suggest new criteria are needed. Epidemiologic and prospective studies have been difficult to perform because of over-reliance on the complete classic triad of symptoms and the different terms and eponyms used. Studies assessing various treatment strategies are ongoing.
authors.affiliation: Department of Internal Medicine, Division of Rheumatology, University of South Florida, 12901 Bruce B. Downs Boulevard, MDC 81, Tampa, FL 33612, USA. jocarter@health.usf.edu
authors.forename: John D
authors.initials: JD
authors.lastname: Carter
authors.forename: Alan P
authors.initials: AP
authors.lastname: Hudson
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016918:Arthritis, Reactive / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D002167:Campylobacter / Q000472:pathogenicity / Q000502:physiology; D002169:Campylobacter Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D002689:Chlamydia / Q000472:pathogenicity / Q000502:physiology; D002690:Chlamydia Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D004405:Dysentery, Bacillary / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D054884:Host-Pathogen Interactions; D006801:Humans; D000091402:Prohibitins; D012475:Salmonella / Q000472:pathogenicity / Q000502:physiology; D012480:Salmonella Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D012760:Shigella / Q000472:pathogenicity / Q000502:physiology; D015007:Yersinia / Q000472:pathogenicity / Q000502:physiology; D015009:Yersinia Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D000900:Anti-Bacterial Agents; C000717331:PHB2 protein, human; D000091402:Prohibitins